Testing effectiveness (Phase 2)Not Yet RecruitingNCT07539857
What this trial is testing
Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized
Who this might be right for
Kidney Transplant Rejection
Leiden University Medical Center 25